Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

NMDBF

Neonmind Biosciences (PK) (NMDBF)

Neonmind Biosciences Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:NMDBF
DatumZeitQuelleÜberschriftSymbolFirma
28/09/202112h45InvestorsHub NewsWireNeonMind Advances Strategy for Specialty Clinic LaunchUSOTC:NMDBFNeonmind Biosciences Inc (PK)
22/09/202112h30InvestorsHub NewsWireNeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhDUSOTC:NMDBFNeonmind Biosciences Inc (PK)
16/09/202117h39InvestorsHub NewsWireNeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory BoardUSOTC:NMDBFNeonmind Biosciences Inc (PK)
08/09/202112h31InvestorsHub NewsWireNeonMind to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceUSOTC:NMDBFNeonmind Biosciences Inc (PK)
28/07/202113h03InvestorsHub NewsWireDr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory BoardUSOTC:NMDBFNeonmind Biosciences Inc (PK)
29/06/202114h50InvestorsHub NewsWireNeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the USUSOTC:NMDBFNeonmind Biosciences Inc (PK)
10/06/202113h57InvestorsHub NewsWireNeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom ProductsUSOTC:NMDBFNeonmind Biosciences Inc (PK)
28/05/202114h24InvestorsHub NewsWireNeonMind to Commence Trading on the OTCQB Venture MarketUSOTC:NMDBFNeonmind Biosciences Inc (PK)
06/04/202114h10InvestorsHub NewsWireNeonMind Developing Music Playlist for Psychedelic Therapy SessionsUSOTC:NMDBFNeonmind Biosciences Inc (PK)
09/03/202114h00InvestorsHub NewsWireNeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for ObesityUSOTC:NMDBFNeonmind Biosciences Inc (PK)
 Showing the most relevant articles for your search:USOTC:NMDBF